英文名称 |
中文名称 |
CAS号 |
操作 |
(2S)-2-amino-3-(2-chlorophenyl)propanamide |
氯吡格雷杂质 |
2381221-17-4 |
详细
|
BetaMethasone 9,11-Epoxide 17,21-Dipropionate |
环氧倍他米松-17,21-双丙酸盐 |
66917-44-0 |
详细
|
Beclomethasone |
倍氯米松(糠酸莫米松杂质) |
4419-39-0 |
详细
|
Pregna-1,4-diene-3,20-dione, 11-hydroxy-16-methyl-17,21-bis(1-oxopropoxy)-, (11β,16β)- |
倍氯米松杂质 |
71934-47-9 |
详细
|
Beclomethasone Dipropionate Impurity |
倍氯米松二丙酸酯杂质 |
52092-12-3 |
详细
|
(11β,16β)-9-BroMo-11-hydroxy-16-Methyl-17,21-bis(1-oxopropoxy)pregna-1,4-diene-3,20-dione |
倍氯米松杂质D |
52092-14-5 |
详细
|
Propionic acid (9R,10S,11S,13S,16S,17R)-9-bromo-11-hydroxy-17-(2-hydroxy-acetyl)-10,13,16-trimethyl-3-oxo-6,7,8,9,10,11,12,13,14,15,16,17-dodecahydro-3H-cyclopenta[a]phenanthren-17-yl ester |
倍氯米松杂质 |
52092-13-4 |
详细
|
Clobetasone butyrate EP Impurity H |
丁酸氯倍他松EP杂质H |
25122-56-9 |
详细
|
Clopidogrel Impurity 52 |
氯吡格雷杂质52 |
1147350-75-1 |
详细
|
Etoricoxib Impurity 8 |
依托考昔杂质 8 |
1421227-97-5 |
详细
|
Etoricoxib Impurity 13 |
依托考昔杂质13 |
1817735-82-2 |
详细
|
Thieno[3,2-c]pyridine-5(4H)-acetic acid, α-(2-chlorophenyl)-6,7-dihydro-, ethyl ester |
氯吡格雷杂质 |
90055-81-5 |
详细
|
Thieno[3,2-c]pyridinium, 5-[(2-chlorophenyl)methyl]-6,7-dihydro-, bromide (1:1) |
氯吡格雷杂质 |
2418591-13-4 |
详细
|
Etoricoxib Impurity 10 |
依托考昔杂质10 |
316149-01-6 |
详细
|
Etoricoxib Impurity 11 |
依托考昔去甲基杂质 |
202409-31-2 |
详细
|
Benzeneacetic acid, α-amino-2-chloro-, ethyl ester, hydrochloride (1:1), (αS)- |
氯吡格雷杂质 |
2649375-64-2 |
详细
|
(S) - 2 - (2-chlorophenyl) - 2 - ((2 - (thiophene-2-yl) ethyl) amino) methyl acetate hydrochloride |
硫酸氢氯吡格雷杂质F |
141109-19-5 |
详细
|
Clopidogrel EP Impurity F (R-Isomer) |
氯吡格雷EP杂质F (R-异构体) |
1258938-54-3 |
详细
|
1-(2-chlorophenyl)-2-ethoxyethanamine |
氯吡格雷杂质 |
1485619-90-6 |
详细
|
6'-DesMethyl-6'-carboxy Etoricoxib |
依托考昔杂质L |
349536-39-6 |
详细
|
(Z)-1-(6-methylpyridin-3-yl)-2-(4-(methylsulfonyl)phenyl)ethanone oxime |
依地昔布EP杂质D |
1810761-43-3 |
详细
|
6'-DesMethyl-6'-Methylhydroxy Etoricoxib |
依托考昔杂质K |
349536-41-0 |
详细
|
Etoricoxib Impurity 18 |
依托考昔杂质18 |
1027162-35-1 |
详细
|
Etoricoxib Impurity O |
依托考昔杂质O |
307531-95-9 |
详细
|
Pregna-1,4-diene-3,20-dione, 21-(acetyloxy)-9-bromo-11-hydroxy-16-methyl-17-(1-oxopropoxy)-, (11β,16β)- (9CI) |
丙酸倍氯米松杂质9 |
52092-15-6 |
详细
|
Etoricoxib Impurity 9 |
依托考昔杂质9 |
859824-65-0 |
详细
|
5-Chloro-6'-Methyl-3-[4-(Methylsulfonyl)phenyl]-2,3'-bipyridine 1'-Oxide |
依托考昔 N-氧化物 |
325855-74-1 |
详细
|
Etoricoxib Impurity 47 |
依托考昔杂质45 |
2241145-66-2 |
详细
|
2-Methyl-5-(3-(4-(Methylsulfonyl)phenyl)furan-2-yl)pyridine |
依托考昔杂质P |
307531-96-0 |
详细
|
Etoricoxib Impurity 36 |
依托考昔杂质36 |
1798110-01-6 |
详细
|
BetaMethasone 9,11-Epoxide 17-Propionate |
丙酸倍氯米松EP杂质U |
79578-39-5 |
详细
|
9-fluoro-11beta,17,21-trihydroxy-16beta-methylpregna-1,4-diene-3,20-dione 17-propionate |
二丙酸倍他米松EP杂质B |
5534-13-4 |
详细
|
H-D-PHG-OME HCL |
D-苯甘氨酸甲酯盐酸盐(氯吡格雷杂质) |
19883-41-1 |
详细
|
METHYL AMINO(3-CHLOROPHENYL)ACETATE HYDROCHLORIDE |
甲基氨基(3-氯苯基)乙酸盐酸盐(氯吡格雷杂质) |
1351586-91-8 |
详细
|
Clopidogrel Impurity 25 |
氯吡格雷杂质25 |
141109-18-4 |
详细
|
Methyl 2-(2-chlorophenyl)-2-oxoacetate |
(2-氯苯基)氧代乙酸甲酯(氯吡格雷杂质) |
34966-49-9 |
详细
|
Clopidogrel Impurity C |
氯吡格雷N-甲基杂质 |
1346605-15-9 |
详细
|
Methyl2-(2-chlorophenyl)-2-(4,5-dihydrothieno[2,3-c]pyridin-6(7H)-yl)acetatehydrochloride |
氯吡咯雷杂质B |
144750-52-7 |
详细
|
rac-Clopidogrel Carboxylic Acid |
氯吡格雷杂质A |
90055-55-3 |
详细
|
Clopidogrel IMpurity 2 (Clopidogrel IMiniuM IMpurity) |
氯吡格雷溴化吡啶杂质 |
1396607-49-0 |
详细
|
Clopidogrel EP I |
氯吡格雷杂质I |
144750-42-5 |
详细
|
Prasugrel |
普拉格雷杂质(氯吡格雷杂质) |
201049-78-7 |
详细
|
Clopidogrel Impurity O |
氯吡格雷杂质O |
1332612-57-3 |
详细
|
Clopidogrel |
氯吡格雷 |
1314028-89-1 |
详细
|
Clopidogrel EP Impurity E |
氯吡格雷杂质E |
90055-68-8 |
详细
|
Ticlopidine EP Impurity E Bromide |
氯吡格雷杂质PCR0625 带溴盐 |
73099-88-4 |
详细
|
Clopidogrel Impurity 28 |
氯吡格雷杂质28 |
40412-09-7 |
详细
|
Ticlopidine Impurity 2(Ticlopidine EP Impurity B) |
噻氯匹定杂质B(氯吡格雷杂质) |
68559-60-4 |
详细
|
Clopidogrel EP IMpurity D |
氯吡格雷杂质D |
1421283-60-4 |
详细
|
Clopidogrel Impurity 22 |
氯吡格雷杂质22 |
138228-61-2 |
详细
|
Clopidogrel EP Impurity F |
氯吡格雷EP杂质F |
141109-20-8 |
详细
|
Clopidogrel Impurity 3 |
氯吡格雷杂质3 |
53885-64-6 |
详细
|
(S)-2-(2-Chlorophenyl)-2-((2-(thiophen-2-yl)ethyl)amino)aceticacid(ClopidogrelImpurity) |
(S)-2-(2-氯苯基)-2-((2-(噻吩-2-基)乙基)氨基)乙酸(氯吡格雷杂质) |
1015247-87-6 |
详细
|
Clopidogrel bisulfate impurity P |
硫酸氢氯吡格雷杂质P |
2418591-12-3 |
详细
|
Acetamide, 2,2,2-trichloro-N-methyl-N-(4-nitrophenyl)- |
尼达尼布杂质 |
126434-07-9 |
详细
|
Acetamide, 2-chloro-N-methyl-N-(2-nitrophenyl)- |
尼达尼布杂质2 |
2653-15-8 |
详细
|
1H-Indole-6-carboxylic acid, 3-[[[4-[(2-chloroacetyl)methylamino]phenyl]amino]phenylmethylene]-2,3-dihydro-2-oxo-, methyl ester, (3Z)- |
尼达尼布杂质 |
1987887-93-3 |
详细
|
Nintedanib Impurity 52 |
尼达尼布杂质52 |
2410284-89-6 |
详细
|
N-(4-Nitrophenyl)-2,2,2-trichloroacetamide |
尼达尼布杂质 |
4306-32-5 |
详细
|
N-methyl-2-(4-methylpiperazin-1-yl)-N-(4-nitrophenyl)acetamide |
尼达尼布杂质12 |
1139453-98-7 |
详细
|
N-(4-aMinophenyl)-2-chloro-N-MethylacetaMide |
尼达尼布杂质 |
855860-75-2 |
详细
|
1-Piperazinecarboxylic acid, 4-[2-[methyl(4-nitrophenyl)amino]-2-oxoethyl]-, 1,1-dimethylethyl ester |
尼达尼布杂质 |
1277571-69-3 |
详细
|
Nintedanib impurity E |
尼达尼布杂质E |
262366-32-5 |
详细
|
BIBF 1202 |
尼达尼布杂质BIBF 1202 |
894783-71-2 |
详细
|
4-Amino-N-methylaniline |
N-甲基对苯二胺(尼达尼布杂质) |
623-09-6 |
详细
|
Nintedanib-013-CO |
尼达尼布标准品-CO |
2218446-42-3 |
详细
|
N-ACETYLOXINDOLE 97 |
N-乙酰基吲哚酮(尼达尼布杂质) |
21905-78-2 |
详细
|
1-Piperazineacetamide, N-(4-aminophenyl)-N-methyl- |
N-(4-氨基苯基)-N-甲基-2-(哌嗪-1-基)乙酰胺(尼达尼布杂质) |
2243384-71-4 |
详细
|
3-Amino-4-(carboxymethyl)benzoic acid |
3-氨基-4-(羧甲基)苯甲酸(尼达尼布杂质) |
1373232-85-9 |
详细
|
2-OXO-2,3-DIHYDRO-1H-INDOLE-6-CARBOXYLIC ACID |
2-氧代吲哚啉-6-羧酸(尼达尼布杂质) |
334952-09-9 |
详细
|
vildagliptin Impurity Isomer |
维格列汀对映异构体 |
1036959-27-9 |
详细
|
Vildagliptin Impurity 57 |
维格列汀杂质57 |
913980-23-1 |
详细
|
D-ProlinaMide |
D-脯氨酰胺(维格列汀杂质) |
62937-45-5 |
详细
|
Vildagliptin Impurity 2 |
维格列汀杂质2 |
214398-99-9 |
详细
|
vildagliptin Impurity J |
维格列汀杂质J |
207557-35-5 |
详细
|
Vildagliptin Impurity 53 |
维格列汀杂质53 |
700376-84-7 |
详细
|
vildagliptin Impurity Q |
维格列汀杂质Q |
1803168-08-2 |
详细
|
Vildagliptin Impurity 25 |
维格列汀杂质25 |
1563006-28-9 |
详细
|
vildagliptin Impurity R |
维格列汀杂质R |
1803168-09-3 |
详细
|
Vildagliptin Chloroacetyl Nitrile (R)-Isomer |
维格列汀氯乙酰丁腈(R)-异构体 |
565452-98-4 |
详细
|
(R)-1-(2-chloroacetyl)pyrrolidine-2-carboxaMide |
R-1-氯乙酰基-2-氰基吡咯烷(维格列汀杂质) |
1211679-98-9 |
详细
|
Vildagliptin Related Compound F |
维格列汀杂质F |
1789703-36-1 |
详细
|
Vildagliptin IMpurity 2 (Mixture of DiastereoMers) |
维达列汀杂质2(非对映体混合物) |
1036959-23-5 |
详细
|
Acetamide, 2-hydroxy-N-methyl-N-(4-nitrophenyl)- |
尼达尼布杂质 |
1860012-61-8 |
详细
|
Vildagliptin Related Compound H |
维格列汀杂质H |
2253194-13-5 |
详细
|
N1-(4-NITROPHENYL)-2-CHLOROACETAMIDE |
2-氯-N-(4-硝基苯基)乙酰胺(尼达尼布杂质) |
17329-87-2 |
详细
|
Nintedanib Impurity 30 |
尼达尼布杂质30 |
1038972-16-5 |
详细
|
2-CHLORO-N-METHYL-N-(4-NITROPHENYL)ACETAMIDE |
2-氯-N-甲基-N-(4-硝基苯基)乙酰胺(尼达尼布杂质) |
2653-16-9 |
详细
|
Nidanib Impurity 7 |
尼达尼布杂质7 |
262368-25-2 |
详细
|
Vildagliptin Related Compound A |
维格列汀杂质A |
741657-02-3 |
详细
|
Vildagliptin iMpurity K |
维格列汀杂质 K |
565453-39-6 |
详细
|
Vildagliptin Carboxylic Acid |
维格列汀羧酸 |
565453-40-9 |
详细
|
Vildagliptin Impurity 18 |
维格列汀杂质18 |
23500-10-9 |
详细
|
vildagliptin Impurity E |
维格列汀杂质E |
1789703-37-2 |
详细
|
vildagliptin Impurity U |
维格列汀杂质U |
38074-72-5 |
详细
|
Vildagliptin Impurity 13 |
维达列汀杂质13 |
2577-48-2 |
详细
|
vildagliptin Impurity V |
维格列汀杂质V |
1032564-18-3 |
详细
|
Vildagliptin Carboxylic Acid Methyl Ester |
维达列汀羧酸甲酯 |
948574-56-9 |
详细
|
Vildagliptin Impurity ZA6 |
维格列汀杂质ZA6 |
2246354-69-6 |
详细
|
1-(4-CHLOROPHENYL)-2-METHOXY-2-OXO-1-ETHANAMINIUM CHLORIDE |
RS-4-氯苯甘氨酸甲酯盐酸盐(氯吡格雷杂质) |
42718-19-4 |
详细
|
(S)-1-N-CBZ-2-CYANO-PYRROLIDINE |
(S)-1-N-苄氧羰基-2-氰基吡咯烷(维格列汀杂质) |
63808-36-6 |
详细
|